Successful treatment of Netherton syndrome with ustekinumab in a 15-year-old girl
- PMID: 31977080
- DOI: 10.1111/bjd.18892
Successful treatment of Netherton syndrome with ustekinumab in a 15-year-old girl
References
-
- Renner ED, Hartl D, Rylaarsdam S et al. Comèl-Netherton syndrome defined as primary immunodeficiency. J Allergy Clin Immunol 2009; 124:536-43.
-
- Mazereeuw-Hautier J, Vahlquist A, Traupe H et al. Management of congenital ichthyoses: European Guidelines of care, part one. Br J Dermatol 2019; 180:272-81.
-
- Paller AS, Renert-Yuval Y, Suprun M et al. An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis. J Allergy Clin Immunol 2017; 139:152-65.
-
- Fontao L, Laffitte E, Briot A et al. Infliximab infusions for Netherton syndrome: sustained clinical improvement correlates with a reduction of thymic stromal lymphopoietin levels in the skin. J Invest Dermatol 2011; 131:1947-50.
-
- Lwin SM, Hsu CK, Liu L et al. Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14. Br J Dermatol 2018; 178:969-72.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
